These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
711 related articles for article (PubMed ID: 30542206)
1. Pathogenesis and therapeutic interventions for ANCA-associated vasculitis. Nakazawa D; Masuda S; Tomaru U; Ishizu A Nat Rev Rheumatol; 2019 Feb; 15(2):91-101. PubMed ID: 30542206 [TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of ANCA-associated vasculitis. Lenka B; Zdenka H; Eva H Cesk Patol; 2020; 56(2):65-67. PubMed ID: 32493021 [TBL] [Abstract][Full Text] [Related]
3. The involvement of NETs in ANCA-associated vasculitis. Shiratori-Aso S; Nakazawa D Front Immunol; 2023; 14():1261151. PubMed ID: 37781373 [TBL] [Abstract][Full Text] [Related]
4. Neutrophil Extracellular Traps in ANCA-Associated Vasculitis. Söderberg D; Segelmark M Front Immunol; 2016; 7():256. PubMed ID: 27446086 [TBL] [Abstract][Full Text] [Related]
5. Remission of Granulomatosis with Polyangiitis Only After Resection of a Pulmonary Nodule. Kanda R; Nakano K; Nawata A; Iwata S; Nakayamada S; Tanaka Y Intern Med; 2022; 61(18):2803-2808. PubMed ID: 36104178 [TBL] [Abstract][Full Text] [Related]
6. Excessive neutrophil extracellular trap formation in ANCA-associated vasculitis is independent of ANCA. Kraaij T; Kamerling SWA; van Dam LS; Bakker JA; Bajema IM; Page T; Brunini F; Pusey CD; Toes REM; Scherer HU; Rabelink TJ; van Kooten C; Teng YKO Kidney Int; 2018 Jul; 94(1):139-149. PubMed ID: 29606398 [TBL] [Abstract][Full Text] [Related]
7. Formation and Disordered Degradation of Neutrophil Extracellular Traps in Necrotizing Lesions of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Masuda S; Nonokawa M; Futamata E; Nishibata Y; Iwasaki S; Tsuji T; Hatanaka Y; Nakazawa D; Tanaka S; Tomaru U; Kawakami T; Atsumi T; Ishizu A Am J Pathol; 2019 Apr; 189(4):839-846. PubMed ID: 30677396 [TBL] [Abstract][Full Text] [Related]
8. Myeloperoxidase anti-neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti-neutrophil cytoplasmic antibody-associated microscopic polyangiitis. Yoshida M; Yamada M; Sudo Y; Kojima T; Tomiyasu T; Yoshikawa N; Oda T; Yamada M Nephrology (Carlton); 2016 Jul; 21(7):624-9. PubMed ID: 26833773 [TBL] [Abstract][Full Text] [Related]
9. Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report. Shida H; Hashimoto N; Kusunoki Y; Hattanda F; Ogawa Y; Hayashi T; Nakazawa D; Masuda S; Tomaru U; Ishizu A BMC Nephrol; 2018 Jun; 19(1):145. PubMed ID: 29929470 [TBL] [Abstract][Full Text] [Related]
10. Intrinsically Distinct Role of Neutrophil Extracellular Trap Formation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Compared to Systemic Lupus Erythematosus. van Dam LS; Kraaij T; Kamerling SWA; Bakker JA; Scherer UH; Rabelink TJ; van Kooten C; Teng YKO Arthritis Rheumatol; 2019 Dec; 71(12):2047-2058. PubMed ID: 31313503 [TBL] [Abstract][Full Text] [Related]
11. Environmental factors influencing the risk of ANCA-associated vasculitis. Zhao WM; Wang ZJ; Shi R; Zhu YY; Zhang S; Wang RF; Wang DG Front Immunol; 2022; 13():991256. PubMed ID: 36119110 [TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society. Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Okada M; Kunimoto Y; Watanabe T; Inagaki A; Yoshida T; Imaizumi M; Nakamura T; Matsunobu T; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T Auris Nasus Larynx; 2021 Feb; 48(1):2-14. PubMed ID: 32768313 [TBL] [Abstract][Full Text] [Related]
14. New advances in the pathogenesis of ANCA-associated vasculitides. Chen M; Kallenberg CG Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356 [TBL] [Abstract][Full Text] [Related]
15. Neutrophils in ANCA-associated vasculitis: Mechanisms and implications for management. Ge S; Zhu X; Xu Q; Wang J; An C; Hu Y; Yang F; Wang X; Yang Y; Chen S; Jin R; Li H; Peng X; Liu Y; Xu J; Zhu M; Shuai Z Front Pharmacol; 2022; 13():957660. PubMed ID: 36210838 [TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of ANCA-Associated Pulmonary Vasculitis. Alba MA; Jennette JC; Falk RJ Semin Respir Crit Care Med; 2018 Aug; 39(4):413-424. PubMed ID: 30404109 [TBL] [Abstract][Full Text] [Related]
17. Natural Killer Cells in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - A Review of the Literature. Fuchs S; Scheffschick A; Gunnarsson I; Brauner H Front Immunol; 2021; 12():796640. PubMed ID: 35116030 [TBL] [Abstract][Full Text] [Related]
18. [Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: advances in pathogenesis and treatment]. Silva F; Cisternas M Rev Med Chil; 2013 Jun; 141(6):765-73. PubMed ID: 24121580 [TBL] [Abstract][Full Text] [Related]
19. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis. Nakazawa D; Tomaru U; Suzuki A; Masuda S; Hasegawa R; Kobayashi T; Nishio S; Kasahara M; Ishizu A Arthritis Rheum; 2012 Nov; 64(11):3779-87. PubMed ID: 22777766 [TBL] [Abstract][Full Text] [Related]
20. The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis. Takeda S; Watanabe-Kusunoki K; Nakazawa D; Kusunoki Y; Nishio S; Atsumi T Front Immunol; 2019; 10():1334. PubMed ID: 31249574 [No Abstract] [Full Text] [Related] [Next] [New Search]